We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
World - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Report Update: Jun 1, 2025

World - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing
Dec 14, 2024

Novo Holdings to Finalize $16.5 Billion Acquisition of Catalent

All regulatory conditions for Novo Holdings' $16.5 billion acquisition of U.S. contract drug manufacturer Catalent have been satisfied, with the companies anticipating the deal's completion in the coming days, according to Reuters. The acquisition, initiated in February, is strategically aligned with Novo Holdings' goal to enhance production of the widely-used weight-loss drug Wegovy.

This significant business maneuver involves the sale of three Catalent factories, specializing in the sterile filling of injection pens, to Novo Nordisk for $11 billion. The facilities are located in Italy, Belgium, and the United States. As the controlling shareholder of Novo Nordisk, Novo Holdings is poised to leverage this acquisition in expanding its pharmaceutical capabilities surrounding the GLP-1 injectable sensation, Wegovy.

Despite the strategic advantages, Novo Nordisk forecasts a mid single-digit negative impact on its operating profit growth for 2025. Consequently, the company has announced it will forego initiating a share buyback program in the year 2025.

Upon review by the European Commission, it was concluded that the merger poses no competition concerns within the European Economic Area. However, this certainty isn't shared across all stakeholders. Discontent remains among several U.S. consumer groups and labor unions, who have petitioned the Federal Trade Commission (FTC) to reject the acquisition. U.S. Senator Elizabeth Warren has also urged FTC scrutiny of the deal. Although the FTC sought additional information on the acquisition in May, no further updates have emerged since.

According to data from the IndexBox platform, projections for the pharmaceutical industry indicate robust growth outlooks, underpinning strategic mergers such as this one as key drivers for competitive positioning in the global market.

Source: IndexBox Market Intelligence Platform

This report provides an in-depth analysis of the global medicaments containing insulin market. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries:

+ the largest producing countries

Data coverage:

  • Global market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Global production, split by region and country
  • Global trade (exports and imports)
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND THE AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional EditionPRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and its Prospects

    1. MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    2. CONSUMPTION BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    3. MARKET FORECAST TO 2035

  4. 4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION

    Finding New Products to Diversify Your Business

    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCTS
    4. MOST TRADED PRODUCTS
    5. MOST PROFITABLE PRODUCTS FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Export

    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    2. PRODUCTION BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)

  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    2. IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    3. IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)

  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    2. EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    3. EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • United States
    • China
    • Japan
    • Germany
    • United Kingdom
    • France
    • Brazil
    • Italy
    • Russian Federation
    • India
    • Canada
    • Australia
    • Republic of Korea
    • Spain
    • Mexico
    • Indonesia
    • Netherlands
    • Turkey
    • Saudi Arabia
    • Switzerland
    • Sweden
    • Nigeria
    • Poland
    • Belgium
    • Argentina
    • Norway
    • Austria
    • Thailand
    • United Arab Emirates
    • Colombia
    • Denmark
    • South Africa
    • Malaysia
    • Israel
    • Singapore
    • Egypt
    • Philippines
    • Finland
    • Chile
    • Ireland
    • Pakistan
    • Greece
    • Portugal
    • Kazakhstan
    • Algeria
    • Czech Republic
    • Qatar
    • Peru
    • Romania
    • Vietnam

  12. LIST OF TABLES

    1. Key Findings In 2024
    2. Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    3. Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
    4. Per Capita Consumption, by Country, 2022–2024
    5. Production, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    6. Imports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    7. Imports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    8. Import Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    9. Exports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    10. Exports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    11. Export Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    2. Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
    3. Consumption, by Country, 2024
    4. Market Volume Forecast to 2035
    5. Market Value Forecast to 2035
    6. Market Size and Growth, By Product
    7. Average Per Capita Consumption, By Product
    8. Exports and Growth, By Product
    9. Export Prices and Growth, By Product
    10. Production Volume and Growth
    11. Exports and Growth
    12. Export Prices and Growth
    13. Market Size and Growth
    14. Per Capita Consumption
    15. Imports and Growth
    16. Import Prices
    17. Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    18. Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    19. Production, by Country, 2024
    20. Production, In Physical Terms, by Country: Historical Data (2012–2024) and Forecast (2025–2035)
    21. Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    22. Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    23. Imports, In Physical Terms, By Country, 2024
    24. Imports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    25. Imports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    26. Import Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    27. Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    28. Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    29. Exports, In Physical Terms, By Country, 2024
    30. Exports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    31. Exports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    32. Export Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)

Recommended posts

Free Data: Medicaments Containing Insulin But Not Antibiotics - World
Table
Medicaments Containing Insulin But Not Antibiotics - World - Table
Dashboard
Medicaments Containing Insulin But Not Antibiotics - World - Dashboard
Report
Medicaments Containing Insulin But Not Antibiotics - World - Report